Sanford Burnham
  • Sanford Burnham
  • Twitter
  • Facebook
  • Youtube
  • Navigate Sanford-Burnham
    • Main Site
    • Our Mission
    • Research
    • Talent
    • Technology
    • Training & Education
    • Our Supporters
    • News

Beaker

Sanford-Burnham Science Blog

Subscribe

Super athletic mice burn more sugar

by Heather Buschman, Ph.D. on November 30, 2011 at 2:02 pm | 2 Comments
Dr. Daniel Kelly, scientific director at Sanford-Burnham’s Lake Nona campus in Orlando, Fla. and senior author of the study

Dr. Daniel Kelly, scientific director at Sanford-Burnham’s Lake Nona campus in Orlando, Fla. and senior author of the study

Muscle performance and fitness are partly determined by how well your muscle cells use sugar as a fuel source. In turn, exercising improves the muscle’s ability to take up sugars from the bloodstream and burn them for energy. On the flip side, conditions that reduce physical activity—such as obesity or chronic disease—reduce the muscle’s capacity to burn sugar. Sanford-Burnham scientists are now unraveling a mechanism that re-programs metabolic genes in muscles in a way that increases their capacity to use sugar. When activated in mice, this metabolic re-programming dramatically improves exercise performance.

These findings, published December 1 in Genes & Development, reveal new targets that could be explored to increase the ability of muscles to burn sugars—an avenue that could ultimately lead to new prevention or treatment methods for obesity, metabolic syndrome, and diabetes.

“Essentially, these transgenic mice are capable of storing and burning sugars at rates usually only seen in the trained athlete. This allows for supranormal athletic performance,” said Dr. Daniel Kelly, scientific director at Sanford-Burnham’s Lake Nona campus in Orlando, Fla. and senior author of the study.

Dr. Kelly’s mice are special because they’re engineered to produce the protein PPARβ/δ in their muscle tissue. PPARβ/δ is a nuclear receptor, a type of protein that binds DNA to turn genes on or off in response to outside signals—in this case, genes specific to muscle metabolism. Previous studies have shown that mice with high PPARβ/δ levels in their muscles have increased exercise capacity. In this study, the researchers discovered why that is—the muscles of PPARβ/δ mice are better than normal mice at taking up sugar from the bloodstream, storing it, and burning it for energy.

Dr. Kelly and his team also found that PPARβ/δ mice are super fit. Compared to normal mice, they ran longer and faster yet generated lower amounts of lactic acid, considered the chief mediator of exercise-induced muscle pain.

How does PPARβ/δ pull it off? It turns out that exercise stimulates cells to assemble a complex of three proteins: 1) PPARβ/δ; 2) a protein that maintains cellular energy balance (adenosine monophosphate-activated protein kinase or AMPK); and 3) a protein that helps activate muscle-specific genes (MEF2A). Together, these proteins switch on the gene that produces lactate dehydrogenase, an enzyme that directs sugar-derived metabolites into mitochondria, where complete burning of the fuel is possible—effectively converting sugar to energy. It’s likely that this novel mechanism helps activate other genes involved in muscle fitness as well.

“Given the association of obesity and insulin resistance with diets enriched in simple sugars, we find these results promising as a step towards new therapeutics,” Dr. Kelly said. “Previously, members of the PPAR protein family have proven to be difficult drug targets due to the wide variety of effects they have in a cell. However, the findings in this study suggest that strategies for activating only a subset of events downstream of PPARβ/δ are possible. This could lead to favorable metabolic effects on muscle and other tissues.”

###
Original paper:
Zhenji Gan, Eileen M. Burkart-Hartman, Dong-Ho Han, Brian Finck, Teresa C. Leone, Emily Y. Smith, Julio E. Ayala, John Holloszy, & Daniel P. Kelly (2011). The nuclear receptor PPARβ/δ programs muscle glucose metabolism in cooperation with AMPK and MEF2 Genes & Development: doi:10.1101/gad.178434.111

ResearchBlogging.org

Tags: Daniel Kelly, Lake Nona, research publications

Post a Comment Cancel reply

* All fields are required

CAPTCHA Image
Refresh Image

*

2 Comments

  1. anna says:
    December 13, 2012 at 5:41 pm

    Having suffered with high blood sugar, I find that my feet have been affected. I have recently discovered that the foot problems are common with diabetes http://diabetesfeet.wordpress.com/2012/11/06/help-for-diabetic-foot-ulcer/ Exercises just as swimming has been a great help . I use water resistance exercises

    Reply
  2. Norma Haygood says:
    September 5, 2012 at 6:38 pm

    Although never formally diagnosed, I know I have mitochondrial dysfunction. I’ve NEVER been able to excersise or play sports due to easily fatigued and painful muscles. At age 56, I have developed metabolic syndrome and ned to loose 15 lbs in order to get rid of my new diagnosis’ of Reflux, Heart Disease, Hypertension, Hyperlipidemia and Pre-diabetes. If there is any way you can include me in any trials, tests, etc. please contact me! Any time….352-250-1553. I need someone to give me some hope, that some day soon I will be able to work off 15 of the toughest stubbornest most troublemaking pounds I’ve ever put on!
    P.S. I’m 5’2” and weigh 140.
    Norma Haygood

    Reply

Search

Find more information

  • About Beaker
  • Contact us
  • Donate

Please take a quick survey

Which of these items describes you?

Select all that apply. (Question 1 of 5)

Categories

  • Basic Research
  • Cancer
    • Apoptosis & Cell Death Research
    • Signal Transduction
    • Tumor Development
    • Tumor Microenvironment
  • Children's Health
    • Genetic Diseases
    • Muscle Development & Regeneration
    • RNA Biology
  • Diabetes & Obesity
    • Cardiovascular Pathobiology
    • Metabolic Signaling & Disease
  • Drug Discovery
  • Events
  • Graduate School of Biomedical Sciences
  • Grants
  • Infectious & Inflammatory Diseases
    • Bioinformatics & Systems Biology
    • Infectious Diseases
    • Inflammatory Diseases
  • Nanomedicine
  • Neuroscience, Aging, & Stem Cells
    • Degenerative Diseases
    • Development & Aging
    • Stem Cells
  • Other
  • People
  • Sanford-Burnham Supporters
  • Translational Medicine

Search by Keyword

CCRA CIRM collaboration commitment communication community Daniel Kelly Erkki Ruoslahti Evan Snyder events Florida Hospital Fred Levine Genetic Disease Program Guy Salvesen Hudson Freeze John Reed Kristiina Vuori La Jolla Lake Nona Metabolic Signaling metabolism NIH Orlando personalized medicine Prebys Center press proteins Rare Diseases Rare disease symposium research publications Robert Wechsler-Reya Santa Barbara Sara Courtneidge Sheila Collins Stem Cells Steven Smith Stuart Lipton T. Denny Sanford technology Translational Research Institute tumor microenvironment Tumor Microenvironment Program Video Yu Yamaguchi Ze'ev Ronai

© Sanford-Burnham Medical Research Institute. All rights reserved.

Get Cloud PHP Hosting on CatN